Research Advancements for HIV-associated Diffuse Large B-cell Lymphoma
This event will not be live streamed. You can submit your questions in advance by clicking the button "Notify when available"
Join us for an exciting episode as we dive into the latest advancements in treating HIV-associated diffuse large B-cell lymphoma (DLBCL). Doctor and researcher Kathryn Lurain joins HealthTree to talk about the latest research on treatment options, challenges and breakthroughs in patient care, and the future direction in HIV-associated DLBCL treatment.
Whether you’re a healthcare professional, a patient, or someone interested in the field, this podcast offers vital information and a deeper understanding of the innovative treatments for HIV-associated lymphoma.
Thank you to our episode sponsors, Regeneron, and Bristol Myers Squibb.
Kathryn Lurain, M.D., M.P.H.
Dr. Lurain is an Associate Research Physician in the HIV/AIDS Malignancy Branch. She is an expert in the treatment of a variety of HIV-associated cancers, including those caused by Kaposi sarcoma herpesvirus (KSHV). Her clinical research is focused on the development of new immunotherapy-based treatments for HIV-associated lymphomas and other virus-associated cancers. Dr. Lurain is an advocate for people living with HIV and their inclusion in clinical trials. She is trained in the clinical care of sexual and gender minorities.
Kat Richardson
Kat is from Lehi, Utah and is the Health Education Manager for lymphoma. She has worked in healthcare for a decade now, and earned her degree in Community Health Education and Promotion. Kat is passionate about disease prevention as well as improving quality of life and health equity. She enjoys reading, hiking, baking, ice skating, gardening, time with her family and friends, and most of all, spoiling her nieces and nephew.